Skip to main content
Earnings Labs
Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc. (MIRM)

NASDAQ·Healthcare·Biotechnology

$92.90

-0.87%

Mkt Cap $6.09B

Analyst Ratings

Buy

20

Hold

0

Sell

0

Price Target (54 analysts)

$140.20

Range $123.00 – $165.00

Implied Upside

+50.9%

Consensus $140.20 vs current $92.90